Spoken Alpha
Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV is a Healthcare company operating in Biotechnology with a $1.94B market cap.
Behavioral analysis
Disclosures
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add LKFT, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks LKFT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LKFT.
$ curl https://api.spokenalpha.com/v1/companies/LKFTFAQ
Spoken Alpha indexes LKFT's earnings call transcripts at https://spokenalpha.com/companies/LKFT. Each call links to attributed speakers and parsed analyst Q&A.
Lakefront Biotherapeutics NV (LKFT) operates in the Healthcare sector (Biotechnology industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.70 | $1.40 | +21.1% | -4.8% | -4.0% |
| Q4 FY2026 | $1.95 | $1.53 | +27.7% | -3.1% | -4.8% |
| Q3 FY2026 | $1.86 | $1.52 | +22.1% | -7.8% | -6.8% |
| Q2 FY2026 | $1.76 | $1.45 | +21.3% | -3.9% | -2.0% |
| Q1 FY2025 | $1.62 | $1.38 | +17.4% | +1.0% | +1.6% |
| Q4 FY2025 |
| $1.86 |
| $1.45 |
| +28.5% |
| +0.5% |
| +0.6% |
| Q3 FY2025 | $1.73 | $1.45 | +19.1% | -6.5% | -7.0% |
| Q2 FY2025 | $1.98 | $1.60 | +24.0% | -4.5% | -2.0% |
| Q1 FY2024 | $1.76 | $1.52 | +15.7% | -7.2% | -4.5% |
| Q4 FY2024 | $1.94 | $1.62 | +20.0% | -4.8% | -7.6% |